Related Experiment Videos
[The duodenum and non-steroidal anti-inflammatory agents].
G Pippa1, M Apuzzo, M E Bazuro
1Servizio di Gastroenterologia e Endoscopia digestiva, Ospedale S. Eugenio, Roma.
Recenti Progressi in Medicina
|June 1, 1990
Summary
Non-aspirin NSAIDs primarily affect the duodenum, while aspirin affects the stomach. This study confirms NSAID-induced upper digestive bleeding is less severe and recurrent than previously thought.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) are common causes of upper gastrointestinal bleeding.
- Previous research suggests NSAIDs differentially affect the stomach and duodenum.
Purpose of the Study:
- To confirm preliminary data on the differential involvement of the duodenum versus the stomach after non-aspirin NSAID use.
- To evaluate the recurrence rate and prognosis of upper digestive hemorrhage in patients taking NSAIDs.
Main Methods:
- A longitudinal study of 53 patients with upper digestive hemorrhage due to NSAID intake (28 aspirin, 25 non-aspirin NSAIDs) without prior peptic pathology.
- Follow-up observation of 42 patients for two years with different treatments (ranitidine vs. antacids).
- Observation of 107 patients with duodenal ulcer bleeding (51 NSAID-related, 56 non-NSAID-related) treated with H2-antagonists.
Main Results:
- Aspirin and its derivatives primarily affected the gastric mucosa, while non-aspirin NSAIDs predominantly affected the duodenum.
- The annual recurrence rate of upper digestive hemorrhage was low in the observed NSAID patients.
- NSAID-induced duodenal ulcers, though common (approx. 50%), presented as a less severe pathology with no mortality in the short term.
Conclusions:
- NSAID-induced upper digestive bleeding, particularly duodenal ulcers, has a favorable short-term prognosis and low recurrence rates.
- Accurate patient selection and understanding of NSAID-specific effects are crucial for diagnosis and treatment.
- These findings support a more conservative therapeutic approach, potentially limiting aggressive endoscopic or surgical interventions.